Befovacimab (Anti-TFPI)
Product Specifications
CAS Number
2156634-62-5
Synonyms
BAY 1093884
Target
Thrombin
Applications
Proteases
Additionnal Information
Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in haemophilia A/B research. MW: 143.24 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.